Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Efficacy of Esperanza Extract (Petiveria Alliacea) in Patients With Metastatic Gastrointestinal Tumors and Acute Leukemia

NCT05587088 is registered in ClinicalTrials.gov with Hospital Universitario San Ignacio as lead sponsor.

NCT NCT05587088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Efficacy of Esperanza Extract (Petiveria Alliacea) in Patients With Metastatic Gastrointestinal Tumors and Acute Leukemia
Lead sponsor
Hospital Universitario San Ignacio
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 15, 2022
Completion date
June 15, 2023
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, acute leukemia in relapse, acute leukemia lymphoid, acute myeloid leukemia, acute myeloid leukemia, in relapse, colorectal neoplasms, gastric neoplasms malignant, neoplasm, stomach, pancreatic neoplasms